Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: Development and activity against human glioblastoma cells

Journal of Microencapsulation

Volumn 25, Issue 8, 2008, Pages 561-568

  Gil Alegre, María Esther ^a   González Álvarez, Isabel ^a   Gutiérrez Paúls, Laura ^a   Torres Suárez, Ana Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

BCNU; Biodegradable microspheres; Brain tumours; H poly(D,L lactide co glycolide); Interstitial chemotherapy

Indexed keywords

CARMUSTINE; DRUG SOLVENT; MICROSPHERE; POLYGLACTIN; POLYMER; WATER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADABLE IMPLANT; BRAIN TUMOR; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DIFFUSION; DRUG MARKETING; DRUG RELEASE; EMULSION; EVAPORATION; FREEZE DRYING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROPHILICITY; PARTICLE SIZE; TEMPERATURE MEASUREMENT; TUMOR CELL; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; CELL SURVIVAL; DRUG CARRIERS; GLIOBLASTOMA; HUMANS; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 56349107029     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802075799     Document Type: Article

References (22)

1. Behin, A., Hoang-Xuan, K. and Carpentier, AF (2003) Primary brain tumours in adults. Lancet, 361, pp. 323-331.
2. Brem, H. and Gabikian, P. (2001) Biodegradable polymer implants to treat brain tumors. J Contr Rel, 74, pp. 63-67.
3. Brem, H., Piantadosi, S. and Burger, PC (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet, 345, pp. 1008-1012.
4. Cutler, DJ (1978) Numerical deconvolution by least squares: Use of prescribed input functions. J Pharmacokinet Biopharm, 6, pp. 227-231.
5. Emerich, DF, Winn, SR, Hu, Y., Marsh, J., Snodgrass, P., LaFreniere, D., Wiens, T., Hasler, BP and Bartus, RT (2000) Injectable chemotherapeutic microspheres and glioma I: Enhanced survival following implntation into the cavity wall of debulked tumors. Pharm Res, 17, pp. 767-775.
6. Engelhard, HH (2000) The role of interstitial BCNU chemotherapy in the treatment of malignant glioma. Surg Neurol, 53, pp. 458-464.
7. Fleming, AB and Saltzman, WM (2002) Pharmacokinetics of the carmustine implant. Clin Pharmacokinet, 41, pp. 403-419.
8. Fung, LK, Shin, M., Tyler, B., Brem, H. and Saltzman, WM (1996) Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl-1-nitrosourea in the rat brain. Pharm Res, 13, pp. 671-683.
9. Higuchi, T. (1980) Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50, pp. 874-875.
10. Lawson, HC, Sampath, P., Bohan, E., Park, MC, Hussain, N., Olivi, A., Weingart, J., Kleinberg, L. and Brem, H. (2006) Interstitial chemotherapy for malignant gliomas: The Johns Hopkins experience. J Neurooncol.
11. Lesniak, MS, Langer, R. and Brem, H. (2001) Drug delivery to tumors of the central nervous system. Curr Neurol Neurosci Rep, pp. 210-218.
12. Loo, TL, Dion, RL, Dixon, RL and Rale, DP (1966) The antitumor agent 1, 3-bis-(2-chloroethyl)-1-nitrosoures. J. Phar. Sci., 55, pp. 492-498.
13. Pharma, MGI
14. Rainov, NG, Soling, A. and Heidecke, V. (2006) Novel therapies for malignant gliomas: A local affair? Neurosurg Focus 20:E9
15. Saini, M., Roser, F., Samii, M. and Bellinzona, M. (2004) A model for intratumoural chemotherapy in the rat brain. Acta Neurochirurg, 146, pp. 731-734.
16. Seong, H., Khang, G., Choi, S., Lee, CO and Lee, HB (2003) BCNU-loaded poly(D,L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Int J Pharm, 251, pp. 1-12.
17. Torres, AI and Benoit, JP (1996) Formulation of BCNU loaded microspheres: Influence of drug stability and solubility on the design of the microencapsulation procedure. J Microencapsulation, 13, pp. 41-51.
18. Ueda-Kawamitsu, H., Lawson, TA and Gwilt, PR (2002) In vitro pharmacokinetics and pharmacodynamics of 1,3-bis (2-chloroethyl)-1-nitrosoures (BCNU). Biochem Pharmacol, 63, p. 1209.
19. Vogelhuber, W., Spruss, T., Bernhardt, G., Buschaner, A. and Gopferich, A. (2002) Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. Int J Pharm, 238, pp. 111-121.
20. Wang, CC, Li, J. and Teo, CS (1999) The delivery of BCNU to brain tumors. J Cont Rel, 61, pp. 21-41.
21. Wang, HT, Palmer, H., Linhardt, RJ, Flanagan, DR and Schmitt, E. (1990) Degradation of poly(ester) microspheres. Biomaterials, 11, pp. 679-685.
22. Westphal, M., Ram, Z., Riddle, V., Hilt, D. and Bortey, E. (2006) Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial. Acta Neurochirurg, 148, pp. 269-275.